NYSE$CL
Colgate-Palmolive · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Colgate-Palmolive Demonstrated Strong Growth Momentum in Q4 2022
Colgate-Palmolive reported a net sales increase of 5.0% and organic sales growth of 8.5% in Q4 2022. EPS declined 94% to $0.01, driven by goodwill and intangible assets impairment charges related to the Filorga skin health business. On a Base Business basis, EPS declined 3% to $0.77.
- Net sales increased by 5.0% in the fourth quarter.
- Organic sales grew by 8.5% with growth in every division and in all four categories.
- GAAP EPS decreased 94% to $0.01 due to impairment charges.
- Base Business EPS decreased 3% to $0.77.
Headline financials
Revenue & EPS history
Colgate · Revenue · Quarterly
$4.63B
Revenue by segment
Colgate · $4.63B total across 6 segments · Q4 2022
- Pet Nutrition$1.06B+19.8%22.9%
- OPHC Latin America$1.01B+10.3%21.8%
- OPHC North America$966M+3.9%20.9%
- OPHC Asia Pacific$696M-3.9%15.0%
- OPHC Europe$623M-10.7%13.5%
- OPHC Africa/Eurasia$273M+9.6%5.9%
Forward guidance
The Company expects net sales growth to be 2% to 5%, including the benefit from acquisitions and a low-single-digit negative impact from foreign exchange. Organic sales growth is expected to be towards the high end of its long-term targeted range of 3% to 5%.
Tailwinds
- Net sales growth of 2% to 5% expected.
- Benefit from acquisitions of pet food businesses.
- Organic sales growth expected towards the high end of 3% to 5% range.
- Gross profit margin expansion expected on a GAAP basis.
- Double-digit earnings-per-share growth expected on a GAAP basis.
Headwinds
- Low-single-digit negative impact from foreign exchange.
- Increased advertising investment.
- Low to mid-single-digit earnings-per-share growth expected on a non-GAAP basis.
- Uncertain macroeconomic conditions worldwide.
- Challenges in duty-free, travel retail, and pharmacy channels due to government restrictions and reduced consumer mobility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2022
-0.4%
Avg return
Earnings day
+0.4%
Avg return
5 days after
+1.0%
Avg return
30 days after
42%
31 / 73 earnings
Positive
+8.0%
Q4 2025
Best reaction
-9.3%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.2% | +3.3% | +5.7% | |
| Q4 2025 | +8.0% | +10.7% | +16.3% | |
| Q3 2025 | -2.0% | +0.5% | +5.1% | |
| Q2 2025 | -0.4% | +0.9% | +0.3% | |
| Q1 2025 | +1.3% | -0.6% | -0.1% | |
| Q4 2024 | -4.6% | +1.9% | +1.8% | |
| Q3 2024 | -4.0% | -5.1% | -4.8% | |
| Q2 2024 | +4.5% | +2.8% | +8.0% | |
| Q1 2024 | +1.3% | +2.9% | +4.5% | |
| Q4 2023 | +3.4% | +3.7% | +6.2% | |
| Q3 2023 | +1.1% | +2.5% | +5.8% | |
| Q2 2023 | -1.1% | +0.6% | -4.3% | |
| Q1 2023 | +3.5% | +4.3% | -2.2% | |
| Q4 2022 | -3.5% | -0.7% | -3.2% | |
| Q3 2022 | +0.8% | -0.6% | +4.8% | |
| Q2 2022 | +2.4% | +2.8% | +0.0% | |
| Q1 2022 | -7.4% | -5.2% | -2.9% | |
| Q4 2021 | -0.3% | +0.1% | -5.5% | |
| Q3 2021 | -1.2% | +0.5% | +0.2% | |
| Q2 2021 | -4.8% | -6.3% | -7.3% | |
| Q1 2021 | +1.6% | +1.9% | +5.0% | |
| Q4 2020 | -0.8% | -0.3% | -5.0% | |
| Q3 2020 | +4.6% | +9.4% | +10.7% | |
| Q2 2020 | -0.4% | -0.9% | +3.3% | |
| Q1 2020 | -1.1% | -3.5% | +2.9% | |
| Q4 2019 | +7.9% | +9.0% | -2.7% | |
| Q3 2019 | -4.7% | -3.0% | -1.1% | |
| Q2 2019 | +5.1% | -0.3% | +0.4% | |
| Q1 2019 | +3.9% | +3.8% | +3.7% | |
| Q4 2018 | +0.9% | +2.8% | +7.6% | |
| Q3 2018 | -9.3% | -6.7% | -3.2% | |
| Q2 2018 | -0.7% | -1.3% | -0.1% | |
| Q1 2018 | -2.0% | -5.2% | -4.3% | |
| Q4 2017 | -4.6% | -4.0% | -9.1% | |
| Q3 2017 | -2.8% | -0.9% | +1.1% | |
| Q2 2017 | -0.3% | +1.3% | -1.5% | |
| Q1 2017 | -2.0% | -3.0% | +2.9% | |
| Q4 2016 | -5.4% | -5.2% | +7.5% | |
| Q3 2016 | -0.1% | -0.4% | -6.6% | |
| Q2 2016 | +1.6% | +2.2% | +1.6% | |
| Q1 2016 | +2.3% | — | — | |
| Q4 2015 | +1.8% | — | — | |
| Q3 2015 | -2.5% | — | — | |
| Q2 2015 | -1.3% | — | — | |
| Q1 2015 | -1.2% | — | — | |
| Q4 2014 | +3.7% | — | — | |
| Q3 2014 | +1.6% | — | — | |
| Q2 2014 | -3.3% | — | — | |
| Q1 2014 | +2.2% | — | — | |
| Q4 2013 | -0.6% | — | — | |
| Q3 2013 | +0.2% | — | — | |
| Q2 2013 | +3.0% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2012 | -0.9% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | +4.8% | — | — | |
| Q1 2012 | -1.2% | — | — | |
| Q4 2011 | +0.2% | — | — | |
| Q3 2011 | +0.8% | — | — | |
| Q2 2011 | -1.3% | — | — | |
| Q1 2011 | -0.9% | — | — | |
| Q4 2010 | -0.6% | — | — | |
| Q3 2010 | +2.1% | — | — | |
| Q2 2010 | -5.8% | — | — | |
| Q1 2010 | -1.1% | — | — | |
| Q1 2009 | -1.1% | — | — | |
| Q4 2009 | -0.0% | — | — | |
| Q3 2008 | +1.2% | — | — | |
| Q3 2009 | +1.2% | — | — | |
| Q2 2009 | -4.5% | — | — | |
| Q4 2007 | -4.5% | — | — | |
| Q2 2008 | -4.5% | — | — | |
| Q4 2008 | -4.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro